Published findings support TTE-first strategies for reducing hospital stays, saving bed hours and cutting healthcare costs   BOSTON, MA – April 28, 2025 – UltraSight™, a digital health leader using machine learning to transform cardiac imaging, today announced the publication of new findings in the Journal of the American College of Emergency Physicians Open (JACEP…

Research underscores how UltraSight’s Real-Time Guidance software empowers broader access to diagnostic-quality cardiovascular imaging—regardless of operator experience.  TEL AVIV, ISRAEL – April 1, 2025 – UltraSight™, a digital health leader using machine learning to transform cardiac imaging, announced the presentation at the American College of Cardiology (ACC) Annual Meeting 2025 of three abstracts highlighting promising…

 Advancing machine learning-driven cardiac imaging to transform workflows, expand access, and enhance clinical decision support for life-saving heart care  DURHAM, NC AND TEL AVIV, ISRAEL – March 12, 2025 – UltraSight™, a digital health leader using machine learning to transform cardiac workflow, announced today its selection as the inaugural participant in the newly launched American…

In a new study, non-sonographers to use UltraSightTM Real-Time Guidance for patients that require echocardiogram “By applying the power of machine learning to imaging, our aim is to streamline patient cardiac workflows for better, more efficient, and effective care” — Davidi Vortman, CEO of UltraSightTM TEL AVIV, ISRAEL February 11, 2025 /EINPresswire.com/ — UltraSightTM, a pioneer…

Leveraging Butterfly Network’s platform, UltraSight seeks to enable patients to access cardiac imaging with real-time AI guidance TEL AVIV, Israel. – June 27, 2024 – Today, UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced it has joined Butterfly Garden, an artificial intelligence (AI) Marketplace launched by Butterfly Network, Inc.…

New collaboration formed to enhance detection and diagnosis of cardiovascular disease

New joint venture creates pathway for introducing UltraSight’s technology to Korean market Tel Aviv, ISRAEL, Feb. 5, 2024 – Today, UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced a partnership with SELVAS Healthcare (subsidiary of SELVAS Group), a Korean-based global digital healthcare company with innovative technology in medical device…

New AI guidance software will allow more medical professionals to conduct cardiac ultrasound in multiple care settings expanding patient access to cardiac imaging TEL AVIV, Israel, July 27, 2023 — Today, UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced that it has been granted FDA clearance for its AI-powered ultrasound guidance…

New partnership to bring the benefits of cardiac imaging to new healthcare settings NATIONAL HARBOR, MD., June 23, 2023 – Today, UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced a partnership with point-of-care ultrasound innovator EchoNous, to enable more healthcare professionals to perform cardiac ultrasound and help increase patient access…

OnSight Wins TCT connect 2020 Shark Tank Innovation Competition

Findings confirm diagnostic echocardiographic exams can be performed by medical professionals without sonography experience by using UltraSight TEL AVIV, Israel, Nov. 28, 2022 — UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, today announced new findings from a landmark pivotal study. According to the results, UltraSight’s AI guidance and quality…

UltraSight Selected to Conduct a Study Onboard the International Space Station

Images acquired with AI guidance software deemed usable in 100 percent of cardiac patients TEL AVIV, Israel, May 26, 2022 — At the 69th Annual Conference of the Israel Heart Society, UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, and Sheba Medical Center Israel revealed new research findings from a blinded pilot study that…

Expansion of board signals digital health company’s growth and increased focus on creating access to cardiac ultrasound TEL AVIV, Israel, May 3, 2022 — UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, is proud to announce that Ruth Atherton, PhD, JD, has joined its board of directors. Dr. Atherton has a…

Technology developed through partnership to monitor astronaut’s heart during ‘Rakia’ space mission CHICAGO and TEL AVIV, ISRAEL, Sept. 30, 2021 — UltraSight, a digital health pioneer transforming cardiac imaging through the power of AI, announced a new collaboration with GE Healthcare to conduct a cardiac study aboard the Axiom ‘Rakia’ space mission, and the successful completion of Preliminary Design Review (PDR)…

Digital Health company transforming ultrasound industry TEL AVIV, Israel, May 11, 2021 — UltraSight (formerly OnSight Medical), a Digital Health pioneer for cardiac imaging and beyond, announced today that it has closed a $13 million Series B funding round. The investment will be used to advance U.S. clinical programs for its real time, AI guidance in a variety of care…